Roger Vilardaga Viera PhD
Title | Associate Professor |
---|
Institution | Wake Forest School of Medicine |
---|
Department | Implementation Science (Public Health Sciences) |
---|
Address | |
---|
vCard | Download vCard |
---|
|
|
|
Bibliographic
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Rubenstein D, Pacek LR, Smith C, McClernon FJ, Enyioha C, Vilardaga R. Stagnant daily smoking prevalence between 2008 and 2019 among Black and Hispanic adults with serious psychological distress. Drug Alcohol Depend. 2023 Jul 01; 248:109943.
PMID: 37247521.
Citations:
-
Vilardaga R, Thrul J, DeVito A, Kendzor DE, Sabo P, Khafif TC. Review of strategies to investigate low sample return rates in remote tobacco trials: A call to action for more user-centered design research. Addict Neurosci. 2023 Sep; 7.
PMID: 37424632.
Citations:
-
Cioe PA, Schnoll R, Hoeppner BB, Gross R, Hitsman BL, Leone FT, Ashare R, Vilardaga R, Tashima K, Pinkston M, Kahler CW. The Impact of the COVID-19 Pandemic on Stress, Isolation, Smoking Behaviors, and Motivation to Quit in People with HIV Who Smoke. AIDS Behav. 2023 Jun; 27(6):1862-1869.
PMID: 36357808.
Citations:
-
Browne J, Halverson TF, Vilardaga R. Erratum to: Engagement with a digital therapeutic for smoking cessation designed for persons with psychiatric illness fully mediates smoking outcomes in a pilot randomized controlled trial. Transl Behav Med. 2022 May 26; 12(5):722.
PMID: 34875095.
Citations:
-
Halverson TF, Browne J, Thomas SM, Palenski P, Vilardaga R. An examination of neurocognition and theory of mind as predictors of engagement with a tailored digital therapeutic in persons with serious mental illness. Schizophr Res Cogn. 2022 Jun; 28:100236.
PMID: 35242605.
Citations:
-
Vilardaga R, McClernon FJ. Regulatory oversight of behavioral digital therapeutics for addiction treatment: A commentary on Khadjesari et al. Addiction. 2021 Dec; 116(12):3287-3289.
PMID: 34658104.
Citations:
-
Browne J, Halverson TF, Vilardaga R. Engagement with a digital therapeutic for smoking cessation designed for persons with psychiatric illness fully mediates smoking outcomes in a pilot randomized controlled trial. Transl Behav Med. 2021 Sep 15; 11(9):1717-1725.
PMID: 34347865.
Citations:
-
Schnoll R, Bernstein SL, Kaufman A, Gross R, Catz SL, Cioe PA, Hitsman B, Marhefka SL, Pacek LR, Vidrine DJ, Vilardaga R, Edelman EJ, McClure JB, Ashare R, Lockhart E, Crothers K. COVID-19 Challenges Confronted by Smoking Cessation Clinical Trials for People Living With HIV: The Experience of Grantees of the US National Cancer Institute. Nicotine Tob Res. 2021 Aug 18; 23(9):1629-1632.
PMID: 33657227.
Citations:
-
Gowarty MA, Longacre MR, Vilardaga R, Kung NJ, Gaughan-Maher AE, Brunette MF. Usability and Acceptability of Two Smartphone Apps for Smoking Cessation Among Young Adults With Serious Mental Illness: Mixed Methods Study. JMIR Ment Health. 2021 Jul 07; 8(7):e26873.
PMID: 34255699.
Citations:
-
Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ. The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV. Nicotine Tob Res. 2021 Jan 22; 23(2):407-410.
PMID: 32803251.
Citations:
-
Vilardaga R, Rizo J, Palenski PE, Mannelli P, Oliver JA, McClernon FJ. Erratum to: Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Dependence and Serious Mental Illness. Nicotine Tob Res. 2021 Jan 22; 23(2):411.
PMID: 32761194.
Citations:
-
Vilardaga R, Fisher T, Palenski PE, Kumaresan V, Mannelli P, Sweitzer MM, McClernon FJ, Engelhard MM, Sabo PL, Garrison KA. Review of Popularity and Quality Standards of Opioid-Related Smartphone Apps. Curr Addict Rep. 2020 Dec; 7(4):486-496.
PMID: 33777644.
Citations:
-
Vilardaga R, Rizo J, Palenski PE, Mannelli P, Oliver JA, Mcclernon FJ. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness. Nicotine Tob Res. 2020 Aug 24; 22(9):1533-1542.
PMID: 31667501.
Citations:
-
Vilardaga R, Davies PS, Vowles KE, Sullivan MD. Theoretical Grounds of Pain Tracker Self Manager: An Acceptance and Commitment Therapy Digital Intervention for Patients with Chronic Pain. J Contextual Behav Sci. 2020 Jan; 15:172-180.
PMID: 32269915.
Citations:
-
Vilardaga R, Rizo J, Ries RK, Kientz JA, Ziedonis DM, Hernandez K, McClernon FJ. Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness. Transl Behav Med. 2019 Nov 25; 9(6):1076-1086.
PMID: 30445507.
Citations:
-
Vilardaga R, Casellas-Pujol E, McClernon JF, Garrison KA. Mobile Applications for the Treatment of Tobacco Use and Dependence. Curr Addict Rep. 2019 Jun; 6(2):86-97.
PMID: 32010548.
Citations:
-
Oliver JA, Hallyburton MB, Pacek LR, Mitchell JT, Vilardaga R, Fuemmeler BF, McClernon FJ. What Do Smokers Want in A Smartphone-Based Cessation Application? Nicotine Tob Res. 2018 Nov 15; 20(12):1507-1514.
PMID: 29065202.
Citations:
-
Luoma JB, Guinther PM, Lawless DesJardins NM, Vilardaga R. Is shame a proximal trigger for drinking? A daily process study with a community sample. Exp Clin Psychopharmacol. 2018 Jun; 26(3):290-301.
PMID: 29863385.
Citations:
-
Sullivan M, Langford DJ, Davies PS, Tran C, Vilardaga R, Cheung G, Yoo D, McReynolds J, Lober WB, Tauben D, Vowles KE. A Controlled Pilot Trial of PainTracker Self-Manager, a Web-Based Platform Combined With Patient Coaching, to Support Patients' Self-Management of Chronic Pain. J Pain. 2018 Sep; 19(9):996-1005.
PMID: 29605691.
Citations:
-
Vilardaga R, Rizo J, Zeng E, Kientz JA, Ries R, Otis C, Hernandez K. User-Centered Design of Learn to Quit, a Smoking Cessation Smartphone App for People With Serious Mental Illness. JMIR Serious Games. 2018 Jan 16; 6(1):e2.
PMID: 29339346.
Citations:
-
Rosenberg DE, Kadokura E, Morris ME, Renz A, Vilardaga RM. Application of N-of-1 Experiments to Test the Efficacy of Inactivity Alert Features in Fitness Trackers to Increase Breaks from Sitting in Older Adults. Methods Inf Med. 2017 Aug 16; 56(5).
PMID: 28816343.
Citations:
-
Edwards DJ, McEnteggart C, Barnes-Holmes Y, Lowe R, Evans N, Vilardaga R. The Impact of Mindfulness and Perspective-Taking on Implicit Associations Toward the Elderly: a Relational Frame Theory Account. Mindfulness (N Y). 2017 Dec; 8(6):1615-1622.
PMID: 29399210.
Citations:
-
Karkar R, Schroeder J, Epstein DA, Pina LR, Scofield J, Fogarty J, Kientz JA, Munson SA, Vilardaga R, Zia J. TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers. Proc SIGCHI Conf Hum Factor Comput Syst. 2017 May 02; 2017:6850-6863.
PMID: 28516175.
Citations:
-
Rector K, Vilardaga R, Lansky L, Lu K, Bennett CL, Ladner RE, Kientz JA. Design and Real-World Evaluation of Eyes-Free Yoga: An Exergame for Blind and Low-Vision Exercise. ACM Trans Access Comput. 2017 Apr; 9(4).
PMID: 29104712.
Citations:
-
McDonell MG, Leickly E, McPherson S, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK. A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness. Am J Psychiatry. 2017 Apr 01; 174(4):370-377.
PMID: 28135843.
Citations:
-
Bhattacharya A, Vilardaga R, Kientz JA, Munson SA. Lessons from Practice: Designing Tools to Facilitate Individualized Support for Quitting Smoking. ACM Trans Comput Hum Interact. 2017; 2017:3057-3070.
PMID: 29123362.
Citations:
-
Villatte JL, Vilardaga R, Villatte M, Plumb Vilardaga JC, Atkins DC, Hayes SC. Acceptance and Commitment Therapy modules: Differential impact on treatment processes and outcomes. Behav Res Ther. 2016 Feb; 77:52-61.
PMID: 26716932.
Citations:
-
Karkar R, Zia J, Vilardaga R, Mishra SR, Fogarty J, Munson SA, Kientz JA. A framework for self-experimentation in personalized health. J Am Med Inform Assoc. 2016 May; 23(3):440-8.
PMID: 26644399.
Citations:
-
Vilardaga R, Rizo J, Kientz JA, McDonell MG, Ries RK, Sobel K. User Experience Evaluation of a Smoking Cessation App in People With Serious Mental Illness. Nicotine Tob Res. 2016 May; 18(5):1032-8.
PMID: 26581430.
Citations:
-
Levin ME, Luoma JB, Vilardaga R, Lillis J, Nobles R, Hayes SC. Examining the role of psychological inflexibility, perspective taking, and empathic concern in generalized prejudice. J Appl Soc Psychol. 2016 Mar; 46(3):180-191.
PMID: 32863424.
Citations:
-
Zeng EY, Vilardaga R, Heffner JL, Mull KE, Bricker JB. Predictors of Utilization of a Novel Smoking Cessation Smartphone App. Telemed J E Health. 2015 Dec; 21(12):998-1004.
PMID: 26171733.
Citations:
-
Lowe JM, McDonell MG, Leickly E, Angelo FA, Vilardaga R, McPherson S, Srebnik D, Roll J, Ries RK. Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients. Alcohol Clin Exp Res. 2015 May; 39(5):905-10.
PMID: 25866234.
Citations:
-
Leickly E, McDonell MG, Vilardaga R, Angelo FA, Lowe JM, McPherson S, Srebnik D, Roll JM, Ries RK. High levels of agreement between clinic-based ethyl glucuronide (EtG) immunoassays and laboratory-based mass spectrometry. Am J Drug Alcohol Abuse. 2015 May; 41(3):246-50.
PMID: 25695340.
Citations:
-
Jones HA, Heffner JL, Mercer L, Wyszynski CM, Vilardaga R, Bricker JB. Web-based acceptance and commitment therapy smoking cessation treatment for smokers with depressive symptoms. J Dual Diagn. 2015; 11(1):56-62.
PMID: 25671683.
Citations:
-
Heffner JL, Vilardaga R, Mercer LD, Kientz JA, Bricker JB. Feature-level analysis of a novel smartphone application for smoking cessation. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):68-73.
PMID: 25397860.
Citations:
-
Yadavaia JE, Hayes SC, Vilardaga R. Using Acceptance and Commitment Therapy to Increase Self-Compassion: A Randomized Controlled Trial. J Contextual Behav Sci. 2014 Oct 01; 3(4):248-257.
PMID: 25506545.
Citations:
-
Roth WR, Vilardaga R, Wolfe N, Bricker JB, McDonell MG. Practical considerations in the design and development of smartphone apps for behavior change. J Contextual Behav Sci. 2014 Oct 01; 3(4):269-272.
PMID: 25485231.
Citations:
-
Vilardaga R, Heffner JL, Mercer LD, Bricker JB. Do counselor techniques predict quitting during smoking cessation treatment? A component analysis of telephone-delivered Acceptance and Commitment Therapy. Behav Res Ther. 2014 Oct; 61:89-95.
PMID: 25156397.
Citations:
-
Bricker JB, Mull KE, Kientz JA, Vilardaga R, Mercer LD, Akioka KJ, Heffner JL. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend. 2014 Oct 01; 143:87-94.
PMID: 25085225.
Citations:
-
McDonell M, McPherson S, Vilardaga R, Srebnik D, Angelo FN, Leickly E, Saxon AJ, Roll J, Ries R. Preliminary findings: Contingency management targeting psycho-stimulant use results in secondary decreases in smoking for severely mentally ill adults. Am J Addict. 2014; 23(4):407-10.
PMID: 24961363.
Citations:
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
Year | Publications |
---|
2013 | 1 |
2014 | 5 |
2015 | 8 |
2017 | 6 |
2018 | 4 |
2019 | 2 |
2020 | 3 |
2021 | 6 |
2022 | 3 |
2023 | 2 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
Vilardaga Viera's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(62)
Derived automatically from this person's publications.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_